Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPalace Capital Regulatory News (PCA)

Share Price Information for Palace Capital (PCA)

Share Price is delayed by 15 minutes
Get Live Data
166.50    0.00 (0.00%)
Bid:
160.00
Ask:
171.50
Spread: 11.50 (7.187%)
Market Cap: £32.51m
PCA Live PriceLast checked at - London Stock Exchange

Intraday Palace Capital Share Chart

Exercise of warrants

18 Feb 2015 09:26

RNS Number : 2147F
Palace Capital PLC
18 February 2015
 



Palace Capital plc

("Palace Capital" or the "Company")

 

Exercise of Warrants

 

Palace Capital announces that it has received notice from Arden Partners plc that it has exercised warrants to acquire 150,000 new ordinary shares in the Company, thereby generating cash proceeds of £300,000 for the Company.

 

Following the exercise of the warrants, the total number of warrants outstanding will be 19,050.

 

Admission to Trading & Total Voting Rights

 

Pursuant to the above exercise, 150,000 new ordinary shares of 10 pence each in the Company (the "New Ordinary Shares") have been issued and allotted and application has been made for their admission to trading on AIM. The New Ordinary Shares will rank pari passu in all respects with the existing ordinary shares. It is expected that admission will become effective and that dealings in the New Ordinary Shares will commence at 8.00 a.m. on 23 February 2015.

 

Following admission of the New Ordinary Shares, the Company's issued share capital will consist of 20,225,673 ordinary shares with voting rights. Palace Capital does not hold any ordinary shares in treasury. The aforementioned figure of 20,225,673 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

-ends-

 

Date: 18 February 2015

 

For further information, please contact:

 

Palace Capital plc

Tel. +44 (0)20 3301 8301

Stanley Davis, Non-Executive Chairman

 

Neil Sinclair, Chief Executive

 

 

 

Allenby Capital Limited

Tel. +44 (0)20 3328 5656

Nick Naylor, Corporate Finance

 

James Reeve, Corporate Finance

 

 

 

Arden Partners plc

Tel: +44 (0)20 7614 5917

Christopher Hardie, Corporate Finance

 

Ciaran Walsh, Corporate Finance

 

 

Broker Profile (Financial PR)

Tel. +44 (0)20 7448 3244

Simon Courtenay

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGGUWGPUPAUBR
Date   Source Headline
12th Jun 20264:45 pmRNSHolding(s) in Company
11th Jun 20267:01 amRNSNotice of General Meeting
11th Jun 20267:00 amRNSInterim Results
10th Jun 20262:14 pmRNSHolding(s) in Company
9th Jun 20261:59 pmRNSHolding(s) in Company
27th May 20264:57 pmRNSHolding(s) in Company
1st May 20261:45 pmRNSTotal Voting Rights
24th Apr 20269:15 amRNSHolding(s) in Company
24th Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Apr 20267:00 amRNSFurther Share Buyback Programme
21st Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Apr 20263:03 pmRNSHolding(s) in Company
17th Apr 20267:00 amRNSShare Buyback Programme
16th Apr 20267:00 amRNSPORTFOLIO VALUATION AS AT 31 MARCH 2026
2nd Apr 20267:00 amRNSHolding(s) in Company
19th Mar 20267:00 amRNSDividend Declaration
4th Mar 20263:02 pmRNSHolding(s) in Company
9th Feb 20267:00 amRNSDisposal Update
23rd Jan 20264:30 pmRNSWithdrawal of Meeting Notice and Board Changes
8th Jan 20267:00 amRNSRESPONSE TO LAKESTREET CAPITAL’S ANNOUNCEMENT
5th Jan 202612:15 pmRNSResponse to Lakestreet Capital Partners AG
5th Jan 20267:00 amRNSLAKESTREET DEMANDS CHANGE AT PALACE CAPITAL
4th Dec 20259:01 amRNSHolding(s) in Company
4th Dec 20259:00 amRNSHolding(s) in Company
1st Dec 202512:47 pmRNSHolding(s) in Company
1st Dec 202512:45 pmRNSHolding(s) in Company
27th Nov 20251:32 pmRNSDividend Declaration
27th Nov 20257:00 amRNSInterim Results
5th Nov 202511:18 amRNSHolding(s) in Company
5th Nov 202511:00 amRNSHolding(s) in Company
28th Oct 20257:00 amRNSHolding(s) in Company
25th Sep 20257:00 amRNSChange of Broker
18th Sep 20257:00 amRNSDividend Declaration
12th Sep 202512:02 pmRNSHolding(s) in Company
10th Sep 202512:07 pmRNSHolding(s) in Company
4th Sep 20251:59 pmRNSHolding(s) in Company
3rd Sep 202511:19 amRNSHolding(s) in Company
3rd Sep 20257:00 amRNSTransaction in Own Shares
28th Aug 20257:00 amRNSResult of Tender Offer
26th Aug 202512:32 pmRNSResult of General Meeting
31st Jul 20257:00 amRNSProposed Tender Offer & Notice of General Meeting
9th Jul 202511:00 amRNSResult of AGM
6th Jun 202511:00 amRNSAnnual Report and Notice of Annual General Meeting
5th Jun 20257:00 amRNSPreliminary Results for year ended 31 March 2025
30th Apr 20257:00 amRNSTRADING AND STRATEGY UPDATE
17th Apr 20257:00 amRNSHolding(s) in Company
11th Apr 20251:30 pmRNSDISPOSALS, DEBT AND CASH UPDATE
11th Mar 20257:00 amRNSDividend Declaration
10th Dec 20241:12 pmRNSHolding(s) in Company
15th Nov 202412:59 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.